One study evaluated the serum levels of inflammatory cytokines in 64 patients with T2DM with CKD, and it was observed that patients with eGFR of 30–59 mL/min/1.73 m2 had increased serum MIP-1α levels. This evidence concerns the gene CCL3 and type 2 diabetes mellitus.